ESC 365 - Eicosapentaenoic acid (EPA) treatment increased the ratio to arachidonic (EPA/AA) and reduced adhesion molecule expression in vascular endothelium during inflammation

EAPC Premium Access

Eicosapentaenoic acid (EPA) treatment increased the ratio to arachidonic (EPA/AA) and reduced adhesion molecule expression in vascular endothelium during inflammation

Session: Primary Care and Risk Factor Management 1

Topic: Lipids, Metabolism

Speaker: Doctor S. Sherratt (Durham, US)

Event: ESC Preventive Cardiology 2023

Congress Presentation

About the speaker

Doctor Samuel Sherratt

Department of Molecular, Cellular, and Biomedical Sciences (MCBS), Durham (United States of America)

0 follower

3 more presentations in this session

The association between circulating lipoprotein subfractions and lipid content in coronary atheromatous plaques assessed by near-infrared spectroscopy

Speaker: Miss J. Saether (Trondheim, NO)

Eicosapentaenoic acid (EPA) reduced expression of neutrophil activation proteins in endothelial cells during challenge with angiotensin II (Ang II) and cytokines

Speaker: Mr S. Sherratt (Durham, US)

Klotho and FGF23 proteins levels and occurrence of myocardial infarction in patients with acute coronary syndrome

Speaker: Doctor A. Olejnik (Wroclaw, PL)

Access the full session

Primary Care and Risk Factor Management 1

Speakers: Doctor S. Sherratt, Miss J. Saether, Mr S. Sherratt, Doctor A. Olejnik

About the event

ESC Preventive Cardiology 2023

13 April - 15 April 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources